Literature DB >> 16136762

Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood.

Celeste Porsbjerg1, Marie-Louise von Linstow, Charlotte Suppli Ulrik, Steen Christian Nepper-Christensen, Vibeke Backer.   

Abstract

BACKGROUND: Studies of the clinical outcome in adulthood of asymptomatic airway hyperresponsiveness (AHR) to histamine or exercise-induced bronchospasm (EIB) detected in childhood in general population samples are sparse and have produced conflicting results.
OBJECTIVE: To describe the outcome of asymptomatic AHR to histamine and EIB.
METHODS: Data from a 12-year follow-up study of a random population sample of individuals aged 7 to 17 years at enrollment were analyzed; only individuals without asthma at enrollment were included in the analysis. AHR to inhaled histamine, EIB, lung function, and sensitization to aeroallergens were measured.
RESULTS: Among the 281 nonasthmatic participants studied, 58 (22%) had AHR to histamine, 33 (12%) had EIB, and 82 (29%) had AHR to histamine and/or EIB. At follow-up, 37.9% of individuals with AHR to histamine and 30% of individuals with EIB had developed current asthma, compared with only 5% of individuals in whom these test results were negative. In patients with AHR to histamine, parental asthma (odds ratio [OR], 12.6; 95% confidence interval [CI], 1.5-108.5), furred pets ownership (OR, 6.0; 95% CI, 1.2-19.6), and dermatitis and/or rhinitis in childhood (OR, 2.2; 95% CI, 1.1-5.1) predicted the subsequent development of asthma, whereas no risk factors for the development of asthma could be identified in individuals with EIB
CONCLUSION: Asymptomatic AHR to histamine and EIB in childhood predict the subsequent development of asthma in adulthood. A genetic disposition to asthma, furred pets ownership, and concomitant rhinitis or dermatitis increase the risk of asthma development in individuals with AHR to histamine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16136762     DOI: 10.1016/S1081-1206(10)61202-1

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  5 in total

Review 1.  Promise and pitfalls in animal-based asthma research: building a better mousetrap.

Authors:  David B Corry; Charles G Irvin
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  Exercise-induced bronchospasm in children.

Authors:  Chris Randolph
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

3.  Exercise-induced asthma in asthmatic children of southern Iran.

Authors:  Abbas Fayezi; Reza Amin; Sara Kashef; Soheila Al Yasin; Mohammad Bahadoram
Journal:  Glob J Health Sci       Date:  2014-09-28

4.  Section 2. Exercise-Induced Bronchospasm: Albuterol versus Montelukast: Highlights of the Asthma Summit 2009: Beyond the Guidelines.

Authors:  Gene Colice; William J Calhoun
Journal:  World Allergy Organ J       Date:  2010-02-15       Impact factor: 4.084

Review 5.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.